Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New kidney transplant drug falls short: study halted early

NCT ID NCT06365437

First seen Mar 16, 2026 · Last updated Apr 29, 2026 · Updated 7 times

Summary

This study compared a new medicine called TCD601 to a standard treatment in people receiving a new kidney. The goal was to see if TCD601 was safer and worked better at preventing organ rejection. The study was stopped early, and only 33 people took part. It was designed for adults aged 18 to 70 getting a kidney from a deceased or living donor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hospital Clinic de Barcelona

    Barcelona, 08036, Spain

  • Hospital Universitari de Bellvitge

    Barcelona, 08907, Spain

  • Innsbruck Medical University

    Innsbruck, A-6020, Austria

  • Karolinska University Hospital

    Stockholm, Huddinge, 14157, Sweden

  • Sahlgrenska University Hospital

    Gothenburg, 41345, Sweden

  • Skåne University Hospital

    Malmo, 20502, Sweden

  • University of Vienna

    Vienna, 1090, Austria

Conditions

Explore the condition pages connected to this study.